^
    The RaDaR assay is a personalized, tumor-informed, highly sensitive technology that tracks a set of up to 48 tumor-specific variants in cell-free DNA (cfDNA) within a cancer patient's blood plasma.
    Cancer:
    Breast Cancer, Colorectal Cancer, Head and Neck Cancer, Lung Cancer
    Method:
    Whole Genome sequencing